Version history

{
  "description": "Methodology challenge: notebook 'Blood-brain barrier transport mechanisms for antibody therapeutics — Rich Analysis Notebook' — evaluate design, statistical methods, and reproducibility.\n\n[TARGET_ARTIFACT type=notebook id=notebook-nb-top5--gap-008]\n[DEBATE_TYPE methodology_challenge]\n[PERSONAS methodologist,statistician,replicator]\n[NUM_ROUNDS 4]\n[AUTO_TRIGGER rule=notebook_debate_scheduler]",
  "domain": "neurodegeneration",
  "status": "resolved",
  "priority_score": 0.92,
  "estimated_effort": "high",
  "evidence_summary": "Resolved by hypothesis h-var-08a4d5c07a: Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration. Score: 0.907. Supporting PMIDs: 33875891, 30610225, 31748742, 27519954, 33741860.",
  "resolution_criteria": "Resolved when the methodologist persona evaluates the 'Blood-brain barrier transport mechanisms for antibody therapeutics — Rich Analysis Notebook' across three dimensions: (1) experimental design — confirming primary data provenance (in vivo BBB permeability assays with radiolabeled or fluorophore-labeled antibodies), appropriate positive/negative controls (transferrin receptor antibodies vsIgG), and statistical power (n >= 6 animals per group); (2) reproducibility — confirming key quantitative findings ( antibody渗透率 >= 0.1% ID/g, or transport rate >= 1e-4 cm/s) replicate across >=2 independent experiments or datasets; (3) analytical methods — confirming appropriate curve fitting (nonlinear regression for transport kinetics), multiple-testing correction, and sensitivity analysis for the transport model parameters. The replicator persona must independently reproduce the main figure's quantitative claims from the notebook's code and data before this gap is considered resolved.",
  "market_price": 0.5
}